Early arrest in B cell development in transgenic mice that express the E41K Bruton's tyrosine kinase mutant under the control of the CD19 promoter region

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6526-6533

  Maas, Alex ^a   Dingjan, Gemma M ^a   Grosveld, Frank ^a   Hendriks, Rudolf W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; IMMUNOGLOBULIN M; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; HUMAN; MOUSE; PLASMA CELL; PRIORITY JOURNAL; PROMOTER REGION; SPLEEN; TRANSGENIC MOUSE; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; LYMPHOPENIA; LYSINE; MICE; MICE, TRANSGENIC; PLASMA CELLS; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; SPLEEN; TRANSGENES;

EID: 0033152749     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Sideras, P., and C. I. E. Smith. 1995. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv. Immunol. 59:135.
2. Desiderio, S. 1997. Role of Btk in B cell development and signalling. Curr. Opin. Immunol. 9:534.
3. Conley, M. E. 1985. B cells in patients with X-linked agammaglobulinemia. J. Immunol. 134:3070.
4. Scher, I. 1982. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv. Immunol. 33:1.
5. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, O. Rathbun, L. Davidson, S. Müller, A. B. Kantor, L. A. Herzenberg, F. S. Rosen, and P. Sideras. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283.
6. Hendriks, R. W., M. F. T. R. De Bruijn, A. Maas, G. M. Dingjan, A. Karis, and F. Grosveld. 1996. Inactivation of Btk by insertion of LacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15:4862.
7. De Weers, M., M. C. M. Verschuren, M. E. M. Kraakman, R. G. J. Mensink, R. K. B. Schuurman, J. J. M. Van Dongen, and R. W. Hendriks. 1993. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 23:3109.
8. Saouf, S. J., S. Mahajan, R. B. Rowley, S. A. Kut, J. Fargnoli, A. L. Burkhardt, S. Tsukada, O. N. Witte, and J. B. Bolen. 1994. Temporal differences in the activation of three classes on non-transmembrane protein tyrosine kinases following B-cell antigen surface engagement. Proc. Natl. Acad. Sci. USA 91:9524.
9. De Weers, M., G. S. Brouns, S. Hishelwood, C. Kinnon, R. K. B. Schuurman, R. W. Hendriks, and J. Borst. 1994. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. J. Biol. Chem. 269:23857.
10. Aoki, Y., K. J. Isselbacher, and S. Pillai. 1994. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligand B cells. Proc. Natl. Acad. Sci. USA 91:10606.
11. Rawlings, D. J., A. M. Scharenberg, H. Park, M. Wahl, S. Lin, R. M. Kato, A.-C. Fluckinger, O. N. Witte, and J.-P. Kinet. 1996. Activation of BTK by a phosphoryiation mechanism initiated by SRC family kinases. Science 271:822.
12. Wahl, M. I., A.-C. Fluckinger, R. M. Kato, H. Park, O. N. Witte, and D J. Rawlings. 1997. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc. Natl. Acad. Sci. USA 94:11526.
13. Salim, K., M. J. Bottomley, E. Querfurth, M. J. Zvelebil, I. Gout, R. Scaife, R. L. Margolis, R. Gigg, E. C. I. Smith, and P. C. Discoll. 1996. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15:6241.
14. 3)/Tec kinase-dependent calcium signalling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1961.
15. Holland, S., R. N. Pearse, T. Kurosaki, and J. V. Ravetch. 1998. SHIP modulates immune receptor responses by regulating membrane associations of Btk. Immunity 8:509.
16. 2+ following B-cell receptor activation. EMBO J. 17:1973.
17. Hyvonen, M., and M. Saraste. 1997. Structure of the PH domain and Btk motif from Bniton's lyrosine kinase: molecular explanations for X-linked agammaglobulinemia. EMBO J. 16:3396.
18. Li, T., S. Tsukada, A. Satterthwaite, M. H. Havlik, H. Park, K. Takatsu, and O. N. Witte. 1995. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain Immunity 2:451.
19. Dingjan, G. M., A. Maas, M. C. Nawijn, L. Smit, J. S. A. Voerman, F. Orosveld, and R. W. Hendriks. 1998. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase. EMBO J. 17:5309.
20. Kozmik, Z., S. Wang, P. Dörfler, B. Adams, and M. Busslinger. 1992. The promotor of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mot. Cell. Biol. 12:2662.
21. Zhou, L.-J., H. M. Smith, T. J. Waldschmidt, R. Schwarting, and T. F. Tedder. 1994. Tissue-specific expression of the human CD 19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol. Cell. Biol. 14: 3884.
22. Lund, T., F. Grosveld, and R. A. Flavell. 1982. Isolation of transforming DNA by cosmid rescue. Proc. Natl. Acad. Sci. USA 79:520.
23. Maas, A., G. M. Dingjan, H. F. J. Savelkoul, C. Kinnon, F. Grosveld, and R. W. Hendriks. 1997. The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene. Eur. J. Immunol. 27:2180.
24. Leenen, P. J. M., K. Radosevic, J. Voerman, B. Salomon, N. Van Rooijen, D. Klatzman, and W. Van Ewijk. 1997. Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover. J. Immunol. 160:2166.
25. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25.
26. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31.
27. Rajewski, K. 1996. Clonal selection and learning in the antibody system. Nature 381:751.
28. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213.
29. hi splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151:4431.
30. Drabek, D., S. Raguez, T. P. M. De Wit, G. M. Dingjan, H. F. J. Savelkoul, F. Orosveld, and R. W. Hendriks. 1997. Correction of the Xid phenotype by transgenic expression of human Btk under the control of class II MHC Ea locus control region. Proc. Natl. Acad. Sci. USA 94:610.
31. Melamed, D., R. J. Benschop, J. C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor editing. Cell 92:173.
32. Goodnow, C. C., J. G. Cyster, S. B. Hartley, S. E. Bell, M. P. Cooke, J. I. Healy, S. Akkaraju, J. C. Rathmell, S. L. Pogue, and K. P. Shokat. 1995. Self-tolerance checkpoint in B lymphocyte development. Adv. Immunol. 59:279.
33. Tiegs, S. L., D. Russell, and D. Nemazee. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009.
34. Kawakami, Y., T. Miura, R. Bissonnette, D. Hata, W. N. Kahn, T. Kitamura, M. Maeda-Yamamoto, S. E. Hartman, L. Yao, F. W. Alt, and T. Kawakami. 1997. Bruton's tyrosine kinase regulated apoptosis and JNK/SAPK kinase activity. Proc. Natl. Acad. Sci. USA 94:3938.
35. Uckun, F. M., K. G. Waddick, S. Mahajan, X. Jun, M. Takata, J. Bolen, and T. Kurosaki. 1996. Btk as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells. Science 273:1096.
36. Gu, H., D. Tarlinton, W. Müller, K. Rajewski, and I. Förster. 1991. Most peripheral B cells in mice are ligand-selected. J. Exp. Med. 173:1357.
37. Lam, K.-P., R. Kühn, and K. Rajewski. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90:1073.
38. Torres, R. M., H. Flaswinkel, M. Reth, and K. Rajewski. 1996. Aberrant B cell development and immune responses in mice with a compromised BCR complex. Science 272:1804.
39. Turner, M., A. Gulbranson-Judge, M. E. Quinn, A. E. Walters, I. C. M. MacLennan, and V. L. J. Tybulewicz. 1997. Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J. Exp. Med. 186:2013.
40. Caldwell, R. G., J. B. Wilson, S. J. Anderson, and R. Longnecker. 1998. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405.
41. Longnecker, R., and C. L. Miller. 1996. Regulation of Epstein-Barr virus latency by latent membrane protein 2. Trends Microbiol. 4:38.
42. Hardy, R. R., K. Hayakawa, J. Haaijman, and L. A. Herzenberg. 1982. B cell subpopulations identified by two-colour fluorescence analysis. Nature 297:589.